Empower Advisory Group, LLC
- SEC CIK
- 0001978885
- Latest filing
- Aug 12, 2026
AZN holding history
AstraZeneca PLC in every 13F filed by Empower Advisory Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AZN overviewAll 13F holders of AZNFull Q2 2026 holdings
- Shares (Q2 2026)
- 5,682
- Value
- $1.06M
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,682 | $1.06M | <0.1% | −246−4.1% | Reduced | Holders |
| Q1 2026 | 5,928 | $1.15M | <0.1% | +3,708+167.0% | AddedConverted for a 1-for-2 split | Holders |
| Q4 2025 | 4,441 | $408.3K | <0.1% | −1,082−19.6% | Reduced | Holders |
| Q3 2025 | 5,523 | $423.7K | <0.1% | +515+10.3% | Added | Holders |
| Q2 2025 | 5,008 | $350.0K | <0.1% | −225−4.3% | Reduced | Holders |
| Q1 2025 | 5,233 | $384.6K | <0.1% | +188+3.7% | Added | Holders |
| Q4 2024 | 5,045 | $330.5K | <0.1% | +1,381+37.7% | Added | Holders |
| Q3 2024 | 3,664 | $285.5K | <0.1% | −4,259−53.8% | Reduced | Holders |
| Q2 2024 | 7,923 | $617.9K | <0.1% | −2,789−26.0% | Reduced | Holders |
| Q1 2024 | 10,712 | $725.7K | <0.1% | −472−4.2% | Reduced | Holders |
| Q4 2023 | 11,184 | $753.2K | <0.1% | +749+7.2% | Added | Holders |
| Q3 2023 | 10,435 | $706.7K | <0.1% | +94+0.9% | Added | Holders |
| Q2 2023 | 10,341 | $740.1K | <0.1% | +397+4.0% | Added | Holders |
| Q1 2023 | 9,944 | $695.2K | <0.1% | – | No prior filing | Holders |